Showing 121 - 140 results of 335,831 for search '"Immunotherapy"', query time: 1.42s Refine Results
121
Academic Journal

Authors: Wen J; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: jiachen.a.wen@outlook.com., Wang S; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China., Guo R; Institute for the Animal Health Industry of Yangzhou University, Wuxi Zodolabs Biotech Co. Ltd, Wuxi, 214000, China., Liu D; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: sammyld@163.com.

Source: European journal of medicinal chemistry [Eur J Med Chem] 2023 Jan 05; Vol. 245 (Pt 1), pp. 114884. Date of Electronic Publication: 2022 Oct 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

122
Academic Journal

Authors: Conde E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Casares N; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Mancheño U; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Elizalde E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Vercher E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Capozzi R; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Santamaria E; Hepatology Program, CIMA, University of Navarra, Pamplona, 31008 Navarra, Spain; CIBERehd, Instituto de Salud Carlos III, 28029 Madrid, Spain., Rodriguez-Madoz JR; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Hemat-Oncology Program, CIMA Universidad de Navarra, Pamplona, 31008 Navarra, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain., Prosper F; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Hemat-Oncology Program, CIMA Universidad de Navarra, Pamplona, 31008 Navarra, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain; Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, 31008 Navarra, Spain., Lasarte JJ; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Lozano T; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain. Electronic address: tlmoreda@unav.es., Hervas-Stubbs S; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; CIBERehd, Instituto de Salud Carlos III, 28029 Madrid, Spain. Electronic address: mshervas@unav.es.

Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Jan 04; Vol. 31 (1), pp. 48-65. Date of Electronic Publication: 2022 Aug 31.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

123
Academic Journal

Authors: Lazaroff J; Department of Medicine, Section of Dermatology, University of Chicago, The University of Chicago Medicine, 5841 S Maryland Avenue MC 5067, Chicago, IL 60637, USA. Electronic address: Jake.Lazaroff@uchospitals.edu., Bolotin D; Department of Medicine, Section of Dermatology, University of Chicago, The University of Chicago Medicine, 5841 S Maryland Avenue MC 5067, Chicago, IL 60637, USA.

Source: Dermatologic clinics [Dermatol Clin] 2023 Jan; Vol. 41 (1), pp. 65-77. Date of Electronic Publication: 2022 Oct 28.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Health Sciences Division Country of Publication: United States NLM ID: 8300886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-0520 (Electronic) Linking ISSN: 07338635 NLM ISO Abbreviation: Dermatol Clin Subsets: MEDLINE

124
Academic Journal

Authors: Gustafson MP; Immuno-Gene Therapy Committee, International Society for Cell and Gene Therapy; Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Phoenix, Arizona, USA., Ligon JA; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida, USA., Bersenev A; Immuno-Gene Therapy Committee, International Society for Cell and Gene Therapy; Department of Laboratory Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, USA., McCann CD; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA; Department of Pediatrics, The George Washington University, Washington, DC, USA., Shah NN; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Hanley PJ; Immuno-Gene Therapy Committee, International Society for Cell and Gene Therapy; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA; Department of Pediatrics, The George Washington University, Washington, DC, USA. Electronic address: phanley@childrensnational.org.

Source: Cytotherapy [Cytotherapy] 2023 Jan; Vol. 25 (1), pp. 20-32. Date of Electronic Publication: 2022 Oct 22.

Publication Type: Review; Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

125
Academic Journal

Authors: Guo B; Department of Experimental Statistics, Louisiana State University, Baton Rouge, Louisiana, USA., Zang Y; Department of Biostatistics and Data Science, School of Medicine, Indiana University, Indianapolis, Indiana, USA.; Center for Computational Biology and Bioinformatics, Indiana University, Indianapolis, Indiana, USA., Lin LH; Department of Experimental Statistics, Louisiana State University, Baton Rouge, Louisiana, USA., Zhang R; Department of Physics and Astronomy, Louisiana State University, Baton Rouge, Louisiana, USA.; Department of Radiation Oncology, Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, USA.

Source: Pharmaceutical statistics [Pharm Stat] 2023 Jan; Vol. 22 (1), pp. 143-161. Date of Electronic Publication: 2022 Sep 26.

Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 101201192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-1612 (Electronic) Linking ISSN: 15391604 NLM ISO Abbreviation: Pharm Stat Subsets: MEDLINE

126
Editorial & Opinion

Authors: Desai A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Subbiah V; Department of Investigational Cancer Therapeutics (phase 1 clinical trials program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Source: Cancer [Cancer] 2023 Jan 01; Vol. 129 (1), pp. 11-14. Date of Electronic Publication: 2022 Oct 30.

Publication Type: Editorial

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

127
Academic Journal

Authors: Li H; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China., Fu Q; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China., Muluh TA; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Key Laboratory for Biorheological Science and Technology of Ministry of Education, Bioengineering College of Chongqing University, Chongqing, China., Shinge SAU; Department of Cardiovascular Surgery, The Affiliated Hospital of Southwest Medical University, China., Fu S; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China., Wu J; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.; Department of Cardiovascular Surgery, The Affiliated Hospital of Southwest Medical University, China.; Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

Source: Recent patents on anti-cancer drug discovery [Recent Pat Anticancer Drug Discov] 2023; Vol. 18 (1), pp. 53-65.

Publication Type: Review; Journal Article

Journal Info: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101266081 Publication Model: Print Cited Medium: Internet ISSN: 2212-3970 (Electronic) Linking ISSN: 15748928 NLM ISO Abbreviation: Recent Pat Anticancer Drug Discov Subsets: MEDLINE

128
Academic Journal

Transliterated Title: Développement des CAR-T cells dans les tumeurs solides.

Authors: El Ghazzi N; CHU Gabriel Montpied, service d'oncologie médicale, Clermont-Ferrand, France; Université Clermont Auvergne, Clermont-Ferrand, France., Italiano A; Institut Bergonié, unité de phases précoces, Bordeaux, France; Université de Bordeaux, Bordeaux, France., Bay JO; CHU Gabriel Montpied, service d'oncologie médicale, Clermont-Ferrand, France; Université Clermont Auvergne, Clermont-Ferrand, France., Dougé A; CHU Gabriel Montpied, service d'oncologie médicale, Clermont-Ferrand, France; Université Clermont Auvergne, Clermont-Ferrand, France. Electronic address: adouge@chu-clermontferrand.fr.

Source: Bulletin du cancer [Bull Cancer] 2023 Jan; Vol. 110 (1), pp. 32-41. Date of Electronic Publication: 2022 Dec 19.

Publication Type: English Abstract; Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6917 (Electronic) Linking ISSN: 00074551 NLM ISO Abbreviation: Bull Cancer Subsets: MEDLINE

129
Academic Journal

Authors: An L; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Lin Y; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Deng B; Cytology Laboratory, Beijing Boren Hospital, Beijing, China., Yin Z; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Zhao D; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Ling Z; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Wu T; Department of Hematopoietic Cell Transplantation, Beijing Boren Hospital, Beijing, China., Zhao Y; Department of Hematopoietic Cell Transplantation, Beijing Boren Hospital, Beijing, China., Chang AH; Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China., Tong C; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Liu S; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China. liusy@borenhospital.com.

Source: BMC cancer [BMC Cancer] 2022 Apr 12; Vol. 22 (1), pp. 393. Date of Electronic Publication: 2022 Apr 12.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

HTML Full Text     PDF Full Text
130
Academic Journal

Authors: Dianat-Moghadam H; Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Dianat.h@med.mui.ac.ir., Mahari A; Department of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA., Salahlou R; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Khalili M; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran., Azizi M; Department of Tissue Engineering and Biomaterials, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, Iran., Sadeghzadeh H; Department of Tissue Engineering, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Source: Stem cell research & therapy [Stem Cell Res Ther] 2022 Apr 08; Vol. 13 (1), pp. 150. Date of Electronic Publication: 2022 Apr 08.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512 (Electronic) Linking ISSN: 17576512 NLM ISO Abbreviation: Stem Cell Res Ther Subsets: MEDLINE

HTML Full Text     PDF Full Text
131
Academic Journal

Authors: Carroll R; Centre for Observational Research & Data Sciences, Bristol Myers Squibb, Uxbridge, UK., Bortolini M; Real World Solutions, IQVIA, London, UK., Calleja A; Real World Solutions, IQVIA, London, UK., Munro R; Real World Solutions, IQVIA, London, UK., Kong S; Department of Oncology, University of Calgary, Calgary, AB, Canada., Daumont MJ; Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Braine-l'Alleud, Belgium., Penrod JR; Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USA., Lakhdari K; Health Economics and Market Access Oncology, Bristol Myers Squibb, Saint-Laurent, QC, Canada., Lacoin L; Epi-Fit, Bordeaux, Nouvelle-Aquitaine, France., Cheung WY; Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada. winson.cheung@ahs.ca.

Source: BMC cancer [BMC Cancer] 2022 Mar 10; Vol. 22 (1), pp. 255. Date of Electronic Publication: 2022 Mar 10.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

HTML Full Text     PDF Full Text
132
Academic Journal

Authors: Zhang X; Hebei Yanda Lu Daopei Hospital, Langfang, China.; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China., Yang J; Hebei Yanda Lu Daopei Hospital, Langfang, China.; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China., Li J; Hebei Yanda Lu Daopei Hospital, Langfang, China.; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China., Li W; Hebei Yanda Lu Daopei Hospital, Langfang, China., Song D; Hebei Yanda Lu Daopei Hospital, Langfang, China., Lu XA; Immunochina Pharmaceuticals Co., Ltd., Beijing, China., Wu F; Immunochina Pharmaceuticals Co., Ltd., Beijing, China., Li J; Hebei Senlang Biotechnology, Shijiazhuang, China., Chen D; Hebei Senlang Biotechnology, Shijiazhuang, China., Li X; Beijing Doing Biomedical Co., Ltd., Beijing, China., Xu Z; Bioceltech Therapeutics Co., Ltd., Beijing, China., Liu S; Tianjin Mycure Medical Technology Co., Ltd., Tianjin, China., Li Z; Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China., Ying K; Department of Engineering Physics, Medical Physics and Engineering Institute, Tsinghua University, Beijing, China., Lu P; Hebei Yanda Lu Daopei Hospital, Langfang, China. peihua_lu@126.com.; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China. peihua_lu@126.com.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Mar; Vol. 71 (3), pp. 689-703. Date of Electronic Publication: 2021 Aug 07.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

HTML Full Text     PDF Full Text
133
Academic Journal

Authors: Abu El-Enin MA; Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.; Department of Medicinal Chemistry, Faculty of Pharmacy, National University of Science and Technology, Nasiria, Iraq., Rabie Shehab El-Din EM; Microbiology & Immunology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt., Abdelwahab HW; Chest Medicine Department, Mansoura University, Mansoura, Egypt., Abd El-Maksoud A; Chest Medicine Department, Mansoura University, Mansoura, Egypt., Abd El-Aziz AM; Microbiology & Immunology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt., Shaaban MI; Microbiology & Immunology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt., Attia AN; Agronomy Department, Faculty of agriculture, Mansoura University, Mansoura, Egypt., Aboukamar WA; Department of medical parasitology, Faculty of medicine, Mansoura University, Mansoura, Egypt., Mohei-Aldin S; Microbiology & Immunology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Belal F; Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Source: Journal of clinical laboratory analysis [J Clin Lab Anal] 2022 Mar; Vol. 36 (3), pp. e24261. Date of Electronic Publication: 2022 Feb 11.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 8801384 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2825 (Electronic) Linking ISSN: 08878013 NLM ISO Abbreviation: J Clin Lab Anal Subsets: MEDLINE

HTML Full Text     PDF Full Text
134
Academic Journal

Authors: Ruiz-Leon B; Allergy Section of University Hospital Reina Sofia-IMIBIC, ARADyAL Network, National Institute of Health Carlos III, 14005 Cordoba, Spain., Serrano P; Allergy Section of University Hospital Reina Sofia-IMIBIC, ARADyAL Network, National Institute of Health Carlos III, 14005 Cordoba, Spain., Vidal C; Allergy Department of Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain., Moreno-Aguilar C; Allergy Section of University Hospital Reina Sofia-IMIBIC, ARADyAL Network, National Institute of Health Carlos III, 14005 Cordoba, Spain.

Source: Toxins [Toxins (Basel)] 2022 Feb 08; Vol. 14 (2). Date of Electronic Publication: 2022 Feb 08.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651 (Electronic) Linking ISSN: 20726651 NLM ISO Abbreviation: Toxins (Basel) Subsets: MEDLINE

HTML Full Text     PDF Full Text
135
Academic Journal

Authors: Ma W; Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis School of Medicine, University of California Davis Comprehensive Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA., Pham B; Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis School of Medicine, University of California Davis Comprehensive Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA., Li T; Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis School of Medicine, University of California Davis Comprehensive Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA. thli@ucdavis.edu.; Medical Service, Hematology and Oncology, Veterans Affairs Northern California Health Care System, Mather, CA, USA. thli@ucdavis.edu.

Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2022 Feb; Vol. 39 (1), pp. 51-60. Date of Electronic Publication: 2021 May 05.

Publication Type: Journal Article; Review

Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE

HTML Full Text     PDF Full Text
136
Academic Journal

Authors: Wang LJ; Department of Pediatrics, Shin Kong WHS Memorial Hospital, Taipei, Taiwan.; School of Medicine, Fu-Jen Catholic University, Taipei County, Taiwan., Mu SC; Department of Pediatrics, Shin Kong WHS Memorial Hospital, Taipei, Taiwan.; School of Medicine, Fu-Jen Catholic University, Taipei County, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan., Lin MI; Department of Pediatrics, Shin Kong WHS Memorial Hospital, Taipei, Taiwan., Sung TC; Department of Pediatrics, Shin Kong WHS Memorial Hospital, Taipei, Taiwan., Chiang BL; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan., Lin CH; Department of Pediatrics, Shin Kong WHS Memorial Hospital, Taipei, Taiwan. chlin2000@gmail.com.

Source: Clinical reviews in allergy & immunology [Clin Rev Allergy Immunol] 2022 Feb; Vol. 62 (1), pp. 180-199. Date of Electronic Publication: 2021 Sep 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9504368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0267 (Electronic) Linking ISSN: 10800549 NLM ISO Abbreviation: Clin Rev Allergy Immunol Subsets: MEDLINE

HTML Full Text     PDF Full Text
137
Academic Journal

Authors: Lu J; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China., Ding J; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China., Liu Z; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China., Chen T; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.

Source: International journal of oncology [Int J Oncol] 2022 Feb; Vol. 60 (2). Date of Electronic Publication: 2022 Jan 04.

Publication Type: Journal Article

Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE

HTML Full Text     PDF Full Text
138
Academic Journal

Authors: Staudt RE; Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA., Carlson RD; Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA., Snook AE; Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA.; Department of Microbiology & Immunology, Thomas Jefferson University, Philadelphia, PA, USA.; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Source: Cancer biology & therapy [Cancer Biol Ther] 2022 Dec 31; Vol. 23 (1), pp. 127-133.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

139
Academic Journal

Authors: Chen Y; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Sun J; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Luo Y; Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Liu J; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Wang X; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Feng R; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Huang J; Department of Respiratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Du H; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Li Q; Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China., Tan J; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Ren G; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Wang X; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. wxytsf@sina.com., Li H; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. lihongzhong@cqmu.edu.cn.; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. lihongzhong@cqmu.edu.cn.

Source: Journal of translational medicine [J Transl Med] 2022 Dec 23; Vol. 20 (1), pp. 615. Date of Electronic Publication: 2022 Dec 23.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

HTML Full Text     PDF Full Text
140
Academic Journal

Authors: Laurent PA; Department of Radiation Oncology, Gustave Roussy Cancer Campus; UNICANCER, Villejuif, France.; INSERM U1030, Molecular Radiation Therapy and Therapeutic Innovation, Gustave Roussy Cancer Campus, University of Paris-Saclay, SIRIC SOCRATE, Villejuif, France., Morel D; Drug Development Department (D.I.T.E.P), Gustave Roussy Cancer Campus; UNICANCER, Villejuif, France., Meziani L; INSERM U1030, Molecular Radiation Therapy and Therapeutic Innovation, Gustave Roussy Cancer Campus, University of Paris-Saclay, SIRIC SOCRATE, Villejuif, France., Depil S; Leon Berard Cancer Center, UNICANCER, Lyon, France., Deutsch E; Department of Radiation Oncology, Gustave Roussy Cancer Campus; UNICANCER, Villejuif, France.; INSERM U1030, Molecular Radiation Therapy and Therapeutic Innovation, Gustave Roussy Cancer Campus, University of Paris-Saclay, SIRIC SOCRATE, Villejuif, France.

Source: Oncoimmunology [Oncoimmunology] 2022 Dec 22; Vol. 12 (1), pp. 2158013. Date of Electronic Publication: 2022 Dec 22 (Print Publication: 2023).

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE